Van Hulzen Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,651
| Closed | -$639K | – | 372 |
|
|
2025
Q4 | $639K | Buy |
6,651
+82
| +1% | +$7.96K | 0.05% | 198 |
|
|
2025
Q3 | $626K | Buy |
6,569
+182
| +3% | +$16.7K | 0.05% | 208 |
|
|
2025
Q2 | $557K | Buy |
6,387
+1,326
| +26% | +$112K | 0.05% | 211 |
|
|
2025
Q1 | $455K | Sell |
5,061
-3,313
| -40% | -$296K | 0.04% | 218 |
|
|
2024
Q4 | $669K | Sell |
8,374
-110
| -1% | -$9.52K | 0.05% | 200 |
|
|
2024
Q3 | $764K | Buy |
8,484
+539
| +7% | +$45.3K | 0.06% | 181 |
|
|
2024
Q2 | $625K | Buy |
7,945
+308
| +4% | +$25.3K | 0.04% | 185 |
|
|
2024
Q1 | $666K | Buy |
7,637
+987
| +15% | +$84.2K | 0.04% | 201 |
|
|
2023
Q4 | $548K | Hold |
6,650
| – | – | 0.04% | 214 |
|
|
2023
Q3 | $521K | Buy |
6,650
+3,547
| +114% | +$297K | 0.04% | 203 |
|
|
2023
Q2 | $273K | Sell |
3,103
-37,898
| -92% | -$3.26M | 0.02% | 255 |
|
|
2023
Q1 | $3.3M | Buy |
41,001
+16,813
| +70% | +$1.37M | 0.31% | 67 |
|
|
2022
Q4 | $1.86M | Buy |
24,188
+707
| +3% | +$57.3K | 0.22% | 92 |
|
|
2022
Q3 | $1.9M | Buy |
+23,481
| New | +$2.11M | 0.23% | 90 |
|
|
2021
Q1 | – | Sell |
-2,676
| Closed | -$313K | – | 294 |
|
|
2020
Q4 | $313K | Sell |
2,676
-55,522
| -95% | -$6.11M | 0.05% | 207 |
|
|
2020
Q3 | $6.05M | Sell |
58,198
-11,679
| -17% | -$1.17M | 0.91% | 35 |
|
|
2020
Q2 | $6.41M | Buy |
69,877
+55,070
| +372% | +$5.28M | 0.96% | 34 |
|
|
2020
Q1 | $1.33M | Sell |
14,807
-44,399
| -75% | -$4.72M | 0.29% | 69 |
|
|
2019
Q4 | $6.72M | Sell |
59,206
-11,980
| -17% | -$1.31M | 1.3% | 25 |
|
|
2019
Q3 | $7.73M | Buy |
71,186
+1,011
| +1% | +$105K | 1.63% | 19 |
|
|
2019
Q2 | $6.83M | Buy |
+70,175
| New | +$6.41M | 1.49% | 25 |
|
|
2018
Q2 | – | Sell |
-48,466
| Closed | -$3.89M | – | 211 |
|
|
2018
Q1 | $3.89M | Buy |
48,466
+45,364
| +1,462% | +$3.74M | 1.19% | 33 |
|
|
2017
Q4 | $250K | Buy |
+3,102
| New | +$248K | 0.08% | 177 |
|
|
2017
Q3 | – | Sell |
-2,252
| Closed | -$200K | – | 187 |
|
|
2017
Q2 | $200K | Buy |
+2,252
| New | +$190K | 0.08% | 133 |
|
|
2016
Q4 | – | Sell |
-2,252
| Closed | -$195K | – | 154 |
|
|
2016
Q3 | $195K | Sell |
2,252
-13,050
| -85% | -$1.14M | 0.11% | 110 |
|
|
2016
Q2 | $1.33M | Buy |
15,302
+10,700
| +233% | +$865K | 0.76% | 46 |
|
|
2016
Q1 | $345K | Buy |
4,602
+77
| +2% | +$5.8K | 0.2% | 84 |
|
|
2015
Q4 | $348K | Sell |
4,525
-1,200
| -21% | -$90.3K | 0.22% | 84 |
|
|
2015
Q3 | $383K | Buy |
5,725
+250
| +5% | +$18.4K | 0.25% | 80 |
|
|
2015
Q2 | $406K | Sell |
5,475
-700
| -11% | -$53.5K | 0.22% | 90 |
|
|
2015
Q1 | $482K | Buy |
6,175
+1,788
| +41% | +$136K | 0.29% | 79 |
|
|
2014
Q4 | $317K | Sell |
4,387
-9,556
| -69% | -$664K | 0.22% | 84 |
|
|
2014
Q3 | $864K | Sell |
13,943
-4,597
| -25% | -$292K | 0.88% | 41 |
|
|
2014
Q2 | $1.18M | Sell |
18,540
-4,591
| -20% | -$279K | 1.01% | 37 |
|
|
2014
Q1 | $1.42M | Buy |
23,131
+8,514
| +58% | +$496K | 1.44% | 28 |
|
|
2013
Q4 | $839K | Buy |
+14,617
| New | +$829K | 0.73% | 52 |
|
Other funds holding MDT
Van Hulzen Asset Management's MDT Position: Q1 2026 in Review
Van Hulzen Asset Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 6,651 shares — an estimated $639K sold.
Van Hulzen Asset Management first reported a position in MDT in Q4 2013 and held it in 36 quarters. The position peaked at $7.73M in Q3 2019. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Van Hulzen Asset Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Van Hulzen Asset Management sold 6,651 Medtronic shares in Q1 2026, an estimated $639K.
- Van Hulzen Asset Management first reported a position in Medtronic in Q4 2013 and held it in 36 quarters.
- Van Hulzen Asset Management's Medtronic position peaked at $7.73M in Q3 2019.
- 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Van Hulzen Asset Management's 13F filing for Q1 2026, filed 14 May 2026.